Abiopharma

CONSTELLIUM SE (CSTM)

Symbol	CSTM
Name	CONSTELLIUM SE
Sector	INDUSTRIALS
Region	Europe
Industry	Metal Fabrications
Address	40-44 RUE WASHINGTON,WASHINGTON PLAZA, PARIS, 75008, France
Telephone	+33 173014600
Fax	—
Email	—
Website	https://www.constellium.com
Incorporation	UNDEFINED
Incorporated On	—
Employees	—
Fiscal Year	—
Public Since	—
Exchanges	NASDAQ
Auditor	—
Audit Status	NOT PROVIDED
Reporting Status	—
CIK	0001563411
Description	Constellium SE designs and manufactures high value-added aluminum products and solutions, serving primarily the packaging, aerospace, and automotive end-markets. The company is structured into three operating segments: Packaging and Automotive Rolled Products; Aerospace and Transportation and Automotive Structures and Industry. It operates its business mainly in France, the United States, Germany, the Czech Republic, and Others. Constellium earns the majority of its revenue from Packaging and Automotive Rolled Products segment. Its customer base includes firms in packaging, aerospace, and automotive and several premium automotive original equipment manufacturers. Additional info from NASDAQ: Constellium SE designs and manufactures high value-added aluminum products and solutions, serving primarily the packaging, aerospace, and automotive end-markets. The company is structured into three operating segments: Packaging and Automotive Rolled Products; Aerospace and Transportation and Automotive Structures and Industry. It operates its business mainly in France, the United States, Germany, the Czech Republic, and Others. Constellium earns the majority of its revenue from Packaging and Automotive Rolled Products segment. Its customer base includes firms in packaging, aerospace, and automotive and several premium automotive original equipment manufacturers.

2026-08-03 23:25

Director Deslarzes Jean-Christophe 🟢 acquired 1.5K shares of CONSTELLIUM SE (CSTM) at $27.24 Transaction Date: Aug 03, 2026 | Filing ID: 000194

2026-07-29 10:04

(99% Positive) CONSTELLIUM SE (CSTM) Reports Q3 2026 Financial Results

2026-07-29 10:00

Constellium Reports Strong Second Quarter and First Half 2026 Results, including Record Segment Adjusted EBITDA; Raises Full Year 2026 Guidance

2026-07-15 12:30

Constellium to Source Local Renewable Energy for its German Facilities

2026-06-29 10:00

Constellium Sells Automotive Structures Joint Venture in Changchun, China

2026-06-24 12:34

New Form S-3ASR - CONSTELLIUM SE Filed: 2026-06-24 AccNo: 0001563411-26-000183 Size: 1 MB

2026-06-08 13:34

Director Ormerod John 🔴 sold 8.0K shares of CONSTELLIUM SE (CSTM) at $35.01 Transaction Date: Jun 04, 2026 | Filing ID: 000180

2026-06-04 22:21

📋 Ormerod John (Director) plans to sell 8K shares of CONSTELLIUM SE (at $34.80 each, total $278K) Filed: Jun 04, 2026 | ID: 024024

2026-06-01 17:34

Becker Marcus 🔴 sold 10.4K shares of CONSTELLIUM SE (CSTM) at $34.93 Transaction Date: May 28, 2026 | Filing ID: 000178

2026-05-28 16:47

📋 Marcus Becker (Affiliate) plans to sell 10K shares of Constellium SE (at $34.93 each, total $363K) Filed: May 28, 2026 | ID: 000503